Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary CNS lymphoma.

Fred H Hochberg1, Joachim M Baehring, Ephraim P Hochberg

  • 1Massachusetts General Hospital Boston, MA 02114, USA. fhochberg@partners.org

Nature Clinical Practice. Neurology
|January 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hodgkin Lymphoma, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Patterns, risk factors and management of CD19-directed chimeric antigen receptor T-cell therapy failure in CNS lymphoma.

Journal of hematology & oncology·2026
Same author

A prospective study of prophylactic dexamethasone with glofitamab in relapsed/refractory large B-cell lymphoma.

Blood neoplasia·2025
Same author

Central nervous system involvement in chronic lymphocytic leukemia: a real-world analysis.

Leukemia & lymphoma·2025
Same author

Distinct epigenetic and transcriptional profiles of Epstein-Barr virus-positive and negative primary CNS lymphomas.

Neuro-oncology·2024
Same author

Toxicities and outcome after CD19-directed chimeric antigen receptor T-cell therapy for secondary neurolymphomatosis.

American journal of hematology·2024

Primary central nervous system (CNS) lymphoma involves the brain and eye, with unknown spread mechanisms. Methotrexate improves survival, but relapses are common, necessitating new diagnostic and therapeutic targets.

Area of Science:

  • Neurology
  • Oncology
  • Ophthalmology

Background:

  • Primary central nervous system (CNS) lymphoma arises from malignant B lymphocytes invading the brain, eye, meninges, and spinal nerves.
  • The precise mechanism of lymphoma cell dissemination to these sites remains unclear, potentially involving molecular targeting from occult systemic reservoirs.

Purpose of the Study:

  • To summarize the current understanding of primary CNS lymphoma, including its pathogenesis, diagnosis, and treatment.
  • To highlight the need for improved diagnostic tools and therapeutic strategies based on molecular insights.

Main Methods:

  • Review of current literature on primary CNS lymphoma.
  • Analysis of diagnostic advancements (imaging, molecular markers).
  • Evaluation of treatment outcomes with methotrexate-based regimens.

Related Experiment Videos

Main Results:

  • Primary CNS lymphoma diagnosis is aided by improved imaging and molecular markers.
  • Methotrexate-based chemotherapy, with or without radiation, extends survival beyond 5 years.
  • Despite treatment, most patients experience eventual relapse.

Conclusions:

  • Further molecular studies are crucial for identifying therapeutic targets.
  • Development of novel tools for earlier diagnosis and monitoring of treatment response is essential.
  • Enhanced understanding of lymphoma cell homing may lead to more effective therapies.